Captrust Financial Advisors Solid Biosciences Inc. Transaction History

Captrust Financial Advisors

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	BUY	$0.74 - $1.79 $2,823 - $6,830	3,816 New	3,816 $5,000
Q4 2021 Feb 14, 2022	SELL	$1.69 - $2.46 $243 - $354	-144 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$5.37 - $10.72 $773 - $1,543	144 New	144 $1,000

Ticker SLDB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 7,533,080
Market Cap $30.6M
Description
Solid Biosciences Inc. engages in developing therapies for duchenne muscular dystrophy in the United States. The company's lead product candidate is SGT-001, a gene transfer candidate, which is in a Phase I/II clinical trial to drive functional dystrophin protein expression in patients' muscles; and SGT-003, a ext-generation gene transfer candid...

Get notified when there are updates to the investment portfolio of Captrust Financial Advisors, based on Form 13F filings with the SEC.

Stay updated on Captrust Financial Advisors with notifications on news.